Literature DB >> 3119699

Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.

M F Celani1, G Giambuzzi, M Simoni, V Montanini.   

Abstract

Basal prolactin (PRL) levels and PRL responsiveness to thyrotropin-releasing hormone (TRH) were studied in 10 women with primary empty sella (PES) syndrome (mean age 38.2 yr). Hyperprolactinemia (34 to 72 ng/ml) was found in 5 patients (hyperprolactinemic PES, H-PES), whereas 5 patients showed normal (9.5 to 19 ng/ml) PRL levels (normoprolactinemic PES, N-PES). The results were compared with those obtained in 10 healthy women (mean age 32.8 yr, PRL = 7 to 15 ng/ml) and in 8 women with a PRL-secreting pituitary microadenoma (MA) (mean age 37.5 yr, PRL = 39 to 85 ng/ml). The mean basal levels of PRL were significantly higher in patients with H-PES (50.8 +/- 13.2 ng/ml) or MA (64.0 +/- 18.3 ng/ml) than in the control group (10.9 +/- 2.6 ng/ml, p less than 0.02) and in the patients with N-PES (13.9 +/- 3.7 ng/ml, p less than 0.02). In contrast, the relative maximum response (RMR) of PRL to TRH (peak PRL/basal PRL) was significantly lower in the patients with PES (both H-PES and N-PES) or MA (1.4 +/- 0.4, 2.3 +/- 0.7 and 1.2 +/- 0.2, respectively) than in the control subjects (3.6 +/- 1.1; p less than 0.02, less than 0.05 and less than 0.02, respectively). Our results show that the pituitary responsiveness to the acute stimulation with TRH is significantly decreased both in patients with a PRL-secreting pituitary MA and in those with PES. Therefore, the clinical value of the TRH test in distinguishing the PES syndromes from prolactinomas seems to be questionable.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119699     DOI: 10.1007/BF03348162

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Identification of a nonimmunoreactive but highly bioactive form of prolactin in the mouse pituitary by gel electrophoresis.

Authors:  Y N Sinha; S R Baxter
Journal:  Biochem Biophys Res Commun       Date:  1979-01-30       Impact factor: 3.575

2.  Does pseudotumor cerebri cause the empty sella syndrome?

Authors:  K M Foley; J B Posner
Journal:  Neurology       Date:  1975-06       Impact factor: 9.910

Review 3.  Prolactin.

Authors:  A G Frantz
Journal:  N Engl J Med       Date:  1978-01-26       Impact factor: 91.245

Review 4.  Neuroendocrine control of prolactin secretion.

Authors:  D A Leong; L S Frawley; J D Neill
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

5.  Pituitary tumors and hyperprolactinemia.

Authors:  W B Malarkey; J C Johnson
Journal:  Arch Intern Med       Date:  1976-01

6.  Diurnal variation of prolactin secretion differentiates pituitary tumors from the primary empty sella syndrome.

Authors:  W B Malarkey; T J Goodenow; R R Lanese
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

7.  Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

Authors:  D L Kleinberg; G L Noel; A G Frantz
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

8.  The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone.

Authors:  P C Eskildsen; C B Kirkegaard
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

9.  Further studies on basal immunoreactive luteinizing hormone (LH), serum testosterone and pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) in elderly men.

Authors:  P Marrama; V Montanini; M F Celani; G F Baraghini; C Carani; D Cavani; R Negri; G Diazzi
Journal:  Minerva Endocrinol       Date:  1984 Jan-Mar       Impact factor: 2.184

10.  The primary empty sella syndrome: analysis of the clinical characteristics, radiographic features, pituitary function and cerebrospinal fluid adenohypophysial hormone concentrations.

Authors:  R M Jordan; J W Kendall; C W Kerber
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965

View more
  1 in total

1.  TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.

Authors:  P Valensi; M E Combes; G Perret; J R Attali
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.